Cargando…
BHV1 infections: Relevance and spread in Europe
Infections caused by BHV1 are very common in Europe, but the disease pattern is quite different: the diseases of the genital tract are most common, those of the respiratory tract vary in intensity and prevalence. Digestive disorders connected with BHV1 are in general only observed in calves and main...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133897/ https://www.ncbi.nlm.nih.gov/pubmed/1657511 http://dx.doi.org/10.1016/0147-9571(91)90130-6 |
_version_ | 1783517719310630912 |
---|---|
author | Straub, Otto Christian |
author_facet | Straub, Otto Christian |
author_sort | Straub, Otto Christian |
collection | PubMed |
description | Infections caused by BHV1 are very common in Europe, but the disease pattern is quite different: the diseases of the genital tract are most common, those of the respiratory tract vary in intensity and prevalence. Digestive disorders connected with BHV1 are in general only observed in calves and mainly in Belgium. Virus strains causing abortion or encephalitis are only present in a few countries. The same is true for BHV1 induced mastitis. Dermatitis and lesions in the interdigital space seem to be a rare event. BHV1 infections are frequently complicated by bacterial secondary infections, but there is evidence that BHV1 infections can occur simultaneously with bovine virus diarrhoea (BVD) and/or parainfluenza-3 (PI 3) virus. The biggest problem associated with BHV1 infection is the ability of the agent to become latent following a primary infection. The genome of the virus probably remains during the life of the animal in the ganglia of the region where the primary infection occurred. No vaccination can overcome this latent stage. By prophylactic vaccination it is possible to prevent an outbreak of clinical disease but it is impossible to prevent infection followed by the establishment of latency. Eradication programmes in Austria, Denmark and Switzerland have removed most of the seropositive cattle from the bovine populations. Currently a sanitary programme is also being conducted in Germany. |
format | Online Article Text |
id | pubmed-7133897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71338972020-04-08 BHV1 infections: Relevance and spread in Europe Straub, Otto Christian Comp Immunol Microbiol Infect Dis Article Infections caused by BHV1 are very common in Europe, but the disease pattern is quite different: the diseases of the genital tract are most common, those of the respiratory tract vary in intensity and prevalence. Digestive disorders connected with BHV1 are in general only observed in calves and mainly in Belgium. Virus strains causing abortion or encephalitis are only present in a few countries. The same is true for BHV1 induced mastitis. Dermatitis and lesions in the interdigital space seem to be a rare event. BHV1 infections are frequently complicated by bacterial secondary infections, but there is evidence that BHV1 infections can occur simultaneously with bovine virus diarrhoea (BVD) and/or parainfluenza-3 (PI 3) virus. The biggest problem associated with BHV1 infection is the ability of the agent to become latent following a primary infection. The genome of the virus probably remains during the life of the animal in the ganglia of the region where the primary infection occurred. No vaccination can overcome this latent stage. By prophylactic vaccination it is possible to prevent an outbreak of clinical disease but it is impossible to prevent infection followed by the establishment of latency. Eradication programmes in Austria, Denmark and Switzerland have removed most of the seropositive cattle from the bovine populations. Currently a sanitary programme is also being conducted in Germany. Published by Elsevier Ltd. 1991 2002-11-12 /pmc/articles/PMC7133897/ /pubmed/1657511 http://dx.doi.org/10.1016/0147-9571(91)90130-6 Text en Copyright © 1991 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Straub, Otto Christian BHV1 infections: Relevance and spread in Europe |
title | BHV1 infections: Relevance and spread in Europe |
title_full | BHV1 infections: Relevance and spread in Europe |
title_fullStr | BHV1 infections: Relevance and spread in Europe |
title_full_unstemmed | BHV1 infections: Relevance and spread in Europe |
title_short | BHV1 infections: Relevance and spread in Europe |
title_sort | bhv1 infections: relevance and spread in europe |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133897/ https://www.ncbi.nlm.nih.gov/pubmed/1657511 http://dx.doi.org/10.1016/0147-9571(91)90130-6 |
work_keys_str_mv | AT straubottochristian bhv1infectionsrelevanceandspreadineurope |